DE1138509B - Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen - Google Patents

Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen

Info

Publication number
DE1138509B
DE1138509B DEB55507A DEB0055507A DE1138509B DE 1138509 B DE1138509 B DE 1138509B DE B55507 A DEB55507 A DE B55507A DE B0055507 A DEB0055507 A DE B0055507A DE 1138509 B DE1138509 B DE 1138509B
Authority
DE
Germany
Prior art keywords
concentrate
foot
mouth disease
virus
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEB55507A
Other languages
German (de)
English (en)
Inventor
Dr Max Schoenenberger
Dr Bernhard Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DEB55507A priority Critical patent/DE1138509B/de
Priority to LU39322D priority patent/LU39322A1/xx
Priority to BE597049A priority patent/BE597049A/fr
Publication of DE1138509B publication Critical patent/DE1138509B/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DEB55507A 1959-11-12 1959-11-12 Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen Pending DE1138509B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DEB55507A DE1138509B (de) 1959-11-12 1959-11-12 Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen
LU39322D LU39322A1 (US20100012521A1-20100121-C00001.png) 1959-11-12 1960-10-22
BE597049A BE597049A (fr) 1959-11-12 1960-11-14 Procédé de préparation de vaccins antiaphteux concentrés

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB55507A DE1138509B (de) 1959-11-12 1959-11-12 Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen

Publications (1)

Publication Number Publication Date
DE1138509B true DE1138509B (de) 1962-10-25

Family

ID=6971014

Family Applications (1)

Application Number Title Priority Date Filing Date
DEB55507A Pending DE1138509B (de) 1959-11-12 1959-11-12 Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen

Country Status (3)

Country Link
BE (1) BE597049A (US20100012521A1-20100121-C00001.png)
DE (1) DE1138509B (US20100012521A1-20100121-C00001.png)
LU (1) LU39322A1 (US20100012521A1-20100121-C00001.png)

Also Published As

Publication number Publication date
LU39322A1 (US20100012521A1-20100121-C00001.png) 1960-12-22
BE597049A (fr) 1961-05-15

Similar Documents

Publication Publication Date Title
EP0011243A1 (de) Verfahren zur Herstellung von Membranproteinen aus Neisseria meningitidis und diese enthaltende Vaccine
DE2816942C2 (de) Impfstoff gegen Rhinitis atrophicans beim Schwein
DE1198489B (de) Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie
EP0222974B1 (de) Verfahren zur Herstellung eines Tollwutimpfstoffes und nach diesem Verfahren erhaltener Impfstoff
DE1138509B (de) Verfahren zur Herstellung von Maul- und Klauenseuche-Konzentratvaccinen
DE2328579A1 (de) Varicella-vaccine
DE664023C (de) Verfahren zur Darstellung von Milz- und Leberextrakten
DE3019554C2 (US20100012521A1-20100121-C00001.png)
DE959048C (de) Verfahren zur Herstellung eines Impfstoffes zur aktiven Schutzimpfung gegen spinale Kinderlaehmung
DE1910715A1 (de) Antimikrobielle Faktoren und deren Verwendung
DE2225548A1 (de) Intravenoes vertraegliche staupe- und hepatitisvaccine
DE539018C (de) Verfahren zur Herstellung lokal immunisierend wirkender Stoffe aus Bakterien (Staphylokokken, Streptokokken, Bacterium coli)
DE212709C (US20100012521A1-20100121-C00001.png)
DE908909C (de) Verfahren zur Herstellung und Verarbeitung pathogener Viren und der sie begleitenden Stoffe
DE499512C (de) Verfahren zur Herstellung von oertlich anzuwendenden, aus Bakterienkulturen, z.B. Staphylokokken-, Streptokokkenkulturen usw. gewonnenen, selbst aber bakterienfreien, sterilen, hochbestaendigen Impfstoffen (Topovaccinen)
DE2033946C2 (de) Lebendimpfstoff gegen infektiöse pustulöse Vulvovaginitis [IPV] und infektiöse bovine Rhinotracheitis [IBR]
DE1057733B (de) Herstellung einer konzentrierten Vakzine gegen Maul- und Klauenseuche
DE570692C (de) Verfahren zur Herstellung eines Schutzmittels zur Einspritzung gegen Staupe
DE1617548C3 (de) Verfahren zur Herstellung eines Impfstoffs gegen die Maul- und Klauenseuche
AT36199B (de) Verfahren zur Herstellung von Immunisierungs- und Heilmitteln gegen Infektionskrankheiten.
AT200257B (US20100012521A1-20100121-C00001.png)
DE2510987C2 (de) Verfahren zur Herstellung eines Tetanusimpfstoffes
DE739594C (de) Verfahren zur Herstellung eines Heil- und Schutzserums gegen Staupe
AT226365B (de) Verfahren zur Herstellung von Impfstoffen aus Gewebekulturen gegen ansteckende Schweinelähmung
UA74811C2 (uk) Спосіб одержання екстракту з cyclamen europaeum l. та екстракт, одержаний в такий спосіб, для лікування синуситу